Evidence map›Paper›PMID 41351289›Full record

ArticleJournal of clinical laboratory analysis2026

A Novel Frameshift Variant c.1023_1029del (p.Asp342ArgfsTer54) Leading to Extended Incorrect Protein C Termini in HOMER2 Causing Autosomal Dominant Nonsyndromic Hearing Loss.

Li-Ting Peng, Wei-Qian Wang, Sha-Sha Huang, Min Liu, Su-Yan Yang, Dong-Yang Kang, Xiang Wang, Xue Gao, Yong-Yi Yuan, Jin-Cao Xu

Abstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Li-Ting PengDepartment of Otolaryngology, The PLA Rocket Force Characteristic Medical Center, Beijing, China.ORCID https://orcid.org/0009-0007-5552-5428
Wei-Qian WangDepartment of Otolaryngology, The PLA Rocket Force Characteristic Medical Center, Beijing, China.
Sha-Sha HuangCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Chinese PLA Medical School, Beijing, China.ORCID https://orcid.org/0000-0001-9324-0078
Min LiuDepartment of Otolaryngology, The PLA Rocket Force Characteristic Medical Center, Beijing, China.
Su-Yan YangCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Chinese PLA Medical School, Beijing, China.
Dong-Yang KangCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Chinese PLA Medical School, Beijing, China.
Xiang WangDepartment of Otolaryngology, The PLA Rocket Force Characteristic Medical Center, Beijing, China.
Xue GaoDepartment of Otolaryngology, The PLA Rocket Force Characteristic Medical Center, Beijing, China.ORCID https://orcid.org/0000-0003-4305-1206
Yong-Yi YuanCollege of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Chinese PLA Medical School, Beijing, China.ORCID https://orcid.org/0000-0002-7936-4776
Jin-Cao XuDepartment of Otolaryngology, The PLA Rocket Force Characteristic Medical Center, Beijing, China.

Funding

National Natural Science Foundation of China 82171158National Natural Science Foundation of China 82271177National Natural Science Foundation of China 82371858
6 · The paper itself

Abstract

backgroundHeterozygous variant in HOMER2 is associated with autosomal dominant nonsyndromic hearing loss (ADNSHL), designated as the locus of DFNA68. Only five pathogenic variants in HOMER2 have been identified to date. AIMS/

objectivesThe aim of this study is to investigate the molecular etiology of ADNSHL in a four-generation Chinese family. MATERIAL AND

methodsWhole exome sequencing analysis was conducted to detect the disease-causing variant. Co-segregation analysis was performed using Sanger sequencing.

resultsThe family exhibited autosomal dominant, progressive, post-lingual, nonsyndromic sensorineural hearing loss, similar to that observed in previously reported DFNA68 families. Unlike the initially high-frequency hearing loss observed in the previously reported families, the young proband in our study (IV:4, 18 years old) exhibited typical low-frequency hearing loss. A novel frameshift variant, c.1023_1029del (p.Asp342ArgfsTer54), in HOMER2 was identified, which co-segregated with the hearing loss phenotype in the family. The variant deletes 7 nucleotides, leading to an extended incorrect protein C terminus. Based on the American College of Medical Genetics and Genomics guidelines, the variant c.1023_1029del (p.Asp342ArgfsTer54) is classified as likely pathogenic. CONCLUSIONS AND SIGNIFICANCE: These findings may help expand the spectrum of pathogenic variants of the HOMER2 gene and provide a molecular interpretation for these patients with ADNSHL.

Indexed as

DeafnessFrameshift MutationHearing Loss, SensorineuralHomer Scaffolding ProteinsAdolescentChildChild, PreschoolExome SequencingFemaleHumansMalePedigreeHomer Scaffolding ProteinsADNSHLDFNA68frameshift varianthearing lossHOMER2

Identifiers

PMID41351289
PMCPMC12795987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.